Author

Pernilla Wikström

Umeå UniversityORCID 0000-0002-6347-1999Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:differential expression· 2 Organism:human· 2 Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Research Focus:gene regulatory network inference· 1 Assay:metabolomics· 1 Research Focus:protein structure prediction· 1 Assay:proteomics· 1

Frequent Co-Authors

Ana Bosch Campos· 1 shared Anders R. J. BerghiD· 1 shared André MateusiD· 1 shared Bogdan PopiD· 1 shared Carlos Peula· 1 shared Chloe Williams· 1 shared Eliana DestefanisiD· 1 shared Erik DassiiD· 1 shared

Activity by Year

2025-2025 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 36 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperMolecular Biology

Ana Bosch Campos

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Cancer BiologyFrontiers in Molecular BiosciencesPeer-reviewedApr 7, 2025

Metabolic readouts of tumor instructed normal tissues (TINT) identify aggressive prostate cancer subgroups for tailored therapy

Ilona Dudka, João Figueira, Pernilla Wikström…·Gerhard Gröbner

The paper identifies metabolic signatures in benign prostate tissues near tumors using HR MAS NMR, revealing differences associated with tumor grade and proximity, which could improve prostate cancer diagnostics.

2 citations

humanmetabolomics

𝕏 PostBluesky

Molecular BiologybioRxivPreprintMar 21, 2025

Fibrillarin shapes oncogenic protein pools and ribosomal composition in triple-negative breast cancer

Paula Groza, Kanchan Kumari, Johanna Schott…·Francesca Aguiló

This study shows that Fibrillarin regulates oncogenic protein pools and ribosomal composition in triple-negative breast cancer by modulating rRNA methylation and RPS28 levels.

DOI 10.1101/2025.03.21.644506

humanproteomics

𝕏 PostBluesky